初始药物治疗的作用及胸主动脉腔内修复术对急性A型主动脉夹层伴假腔血栓形成的疗效
该回顾性研究分析60例急性A型主动脉夹层伴假腔血栓形成患者,33例行急诊主动脉修复,27例无并发症且升主动脉直径<50 mm、升主动脉假腔血栓厚度≤10 mm者选择初始药物治疗。初始药物治疗组中15例(56%)需延迟主动脉修复,其中胸主动脉腔内修复术8例、开放手术7例。胸主动脉腔内修复术组30天死亡1例(7%),开放手术组无院内死亡;中位随访24.8个月无主动脉相关死亡,两组免于主动脉事件率无统计学显著差异。
要点
- 初始药物治疗适用于无并发症且升主动脉直径<50 mm、假腔血栓厚度≤10 mm的急性A型主动脉夹层伴假腔血栓形成患者。
- 初始药物治疗组中50%(7/14)住院期间出现新发溃疡样突起。
- 延迟修复中胸主动脉腔内修复术占53%(8/15),显著高于急诊修复组的21%(7/33)(P=0.043)。
核心结论
- 采用急诊主动脉修复、初始药物治疗和延迟主动脉修复相结合的管理策略,对急性A型主动脉夹层伴假腔血栓形成患者取得了良好的临床结局。
- 在所选日本患者中,初始药物治疗联合重复多排CT可发现新发内膜撕裂,部分病例可通过胸主动脉腔内修复术封闭。
- 对该病理使用胸主动脉腔内修复术(原文写作EVAR)获得了可接受的早期和中期结局。
- 需要进一步研究验证该管理程序的安全性和有效性。
研究设计与样本
- 回顾性分析60例急性A型主动脉夹层伴假腔血栓形成患者。
- 33例行急诊主动脉修复,27例无并发症且升主动脉直径<50 mm、升主动脉假腔血栓厚度≤10 mm者选择初始药物治疗。
主要发现
- 初始药物治疗的27例中,14例入院时存在壁内血肿,住院期间7例(50%)出现新发溃疡样突起。
- 出院前12例(44%)仅接受药物治疗,15例(56%)需要延迟主动脉修复,其中胸主动脉腔内修复术8例、开放手术7例。
- 从发病到延迟修复的中位间隔为9天,延迟修复中接受胸主动脉腔内修复术的患者比例显著高于急诊修复组(53% vs 21%;P=0.043)。
- 胸主动脉腔内修复术组(n=15)30天死亡1例(7%),开放手术组(n=33)无院内死亡。
- 中位随访24.8个月期间无主动脉相关死亡,免于主动脉事件率胸主动脉腔内修复术组3年为92.8%、开放手术组3年为88.4%,两组无统计学显著差异(P=0.871)。
局限性
- 原文在结论中写明需要进一步研究验证该管理程序的安全性和有效性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: The optimal treatment for acute type A aortic dissection (AAAD) with thrombosed false lumen (T-FL) of the ascending aorta remains controversial. The goal of this study was to evaluate clinical outcomes of initial medical treatment (IMT) and the effectiveness of thoracic endovascular aortic repair (TEVAR) for AAAD with T-FL. METHODS: We retrospectively analysed 60 patients with AAAD with T-FL. Emergency aortic repair was performed in 33 patients, and IMT was selected in 27 uncomplicated patients with ascending aortic diameter < 50 mm and ascending T-FL thickness ≤ 10 mm. RESULTS: Among the 27 patients who received IMT, 14 had intramural haematomas at admission; however, new ulcer-like projections appeared in 7 (50%) during hospitalization. Before discharge, 12 (44%) were given medical treatment only, and 15 (56%) required delayed aortic repair including TEVAR in 8 and open repair in 7. The median interval from onset to delayed repair was 9 days, and significantly more patients received TEVAR compared to those receiving emergency repair (53% vs 21%; P = 0.043). Between the TEVAR (n = 15) and the open repair (n = 33) groups, 1 (7%) 30-day death occurred in the TEVAR group, whereas no in-hospital deaths occurred in the open repair group. During the median follow-up time of 24.8 months, no aorta-related death was observed, and there were no statistically significant differences in the rate of freedom from aortic events (TEVAR: 92.8%/3 years vs open repair: 88.4%/3 years; P = 0.871). CONCLUSIONS: Our management, using a combination of emergency aortic repair, IMT and delayed aortic repair for AAAD with T-FL, achieved favourable clinical outcomes. Among the selected Japanese patients, IMT with repeated multidetector computed tomography could detect a new intimal tear that could be closed by TEVAR in some cases. Using EVAR for this pathology resulted in acceptable early and midterm outcomes. Further investigations are required to validate the safety and efficacy of this management procedure.
引用
- Masada K, Shinzato K, Koizumi S, et al. Role of initial medical treatment and effectiveness of thoracic endovascular aortic repair for acute type A aortic dissection with thrombosed false lumen. Eur J Cardiothorac Surg. 2023. PMID: 36961338. doi:10.1093/ejcts/ezad102
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。